WallStreetZenWallStreetZen

NASDAQ: AUPH
Aurinia Pharmaceuticals Inc Stock

$5.01+0.01 (+0.2%)
Updated Mar 28, 2024
AUPH Price
$5.01
Fair Value Price
N/A
Market Cap
$724.53M
52 Week Low
$4.85
52 Week High
$12.43
P/E
-9.28x
P/B
1.92x
P/S
7.34x
PEG
N/A
Dividend Yield
N/A
Revenue
$175.51M
Earnings
-$78.02M
Gross Margin
91.9%
Operating Margin
-42.56%
Profit Margin
-44.5%
Debt to Equity
0.45
Operating Cash Flow
-$33M
Beta
0.95
Next Earnings
May 2, 2024
Ex-Dividend
N/A
Next Dividend
N/A

AUPH Overview

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.

Zen Score

–
Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AUPH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

AUPH is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AUPH is good value based on its book value relative to its share price (1.92x), compared to the US Biotechnology industry average (6.21x)
P/B vs Industry Valuation
AUPH is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more AUPH due diligence checks available for Premium users.

Be the first to know about important AUPH news, forecast changes, insider trades & much more!

AUPH News

Valuation

AUPH fair value

Fair Value of AUPH stock based on Discounted Cash Flow (DCF)
Price
$5.01
Fair Value
$8.50
Undervalued by
41.09%
AUPH is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

AUPH price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-9.28x
Industry
14.26x
Market
44.51x

AUPH price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.92x
Industry
6.21x
AUPH is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

AUPH's financial health

Profit margin

Revenue
$45.1M
Net Income
-$26.9M
Profit Margin
-59.6%
AUPH's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
AUPH's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$548.1M
Liabilities
$170.1M
Debt to equity
0.45
AUPH's short-term assets ($424.80M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AUPH's short-term assets ($424.80M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AUPH's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
AUPH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$14.3M
Investing
-$6.3M
Financing
-$5.6M
AUPH's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

AUPH vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
AUPH$724.53M+0.20%-9.28x1.92x
KRRO$721.98M+1.66%-1.70x4.25x
ELVN$727.30M-5.58%-8.75x2.96x
ALT$721.71M+14.51%-6.13x3.72x
FATE$728.40M0.00%-4.48x1.98x

Aurinia Pharmaceuticals Stock FAQ

What is Aurinia Pharmaceuticals's quote symbol?

(NASDAQ: AUPH) Aurinia Pharmaceuticals trades on the NASDAQ under the ticker symbol AUPH. Aurinia Pharmaceuticals stock quotes can also be displayed as NASDAQ: AUPH.

If you're new to stock investing, here's how to buy Aurinia Pharmaceuticals stock.

What is the 52 week high and low for Aurinia Pharmaceuticals (NASDAQ: AUPH)?

(NASDAQ: AUPH) Aurinia Pharmaceuticals's 52-week high was $12.43, and its 52-week low was $4.85. It is currently -59.69% from its 52-week high and 3.3% from its 52-week low.

How much is Aurinia Pharmaceuticals stock worth today?

(NASDAQ: AUPH) Aurinia Pharmaceuticals currently has 144,617,762 outstanding shares. With Aurinia Pharmaceuticals stock trading at $5.01 per share, the total value of Aurinia Pharmaceuticals stock (market capitalization) is $724.53M.

Aurinia Pharmaceuticals stock was originally listed at a price of $4.00 in Sep 3, 2014. If you had invested in Aurinia Pharmaceuticals stock at $4.00, your return over the last 9 years would have been 25.25%, for an annualized return of 2.53% (not including any dividends or dividend reinvestments).

How much is Aurinia Pharmaceuticals's stock price per share?

(NASDAQ: AUPH) Aurinia Pharmaceuticals stock price per share is $5.01 today (as of Mar 28, 2024).

What is Aurinia Pharmaceuticals's Market Cap?

(NASDAQ: AUPH) Aurinia Pharmaceuticals's market cap is $724.53M, as of Mar 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Aurinia Pharmaceuticals's market cap is calculated by multiplying AUPH's current stock price of $5.01 by AUPH's total outstanding shares of 144,617,762.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.